Albert D Mason Inc. Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Albert D Mason Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 12.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 594 shares of the healthcare conglomerate’s stock after buying an additional 68 shares during the quarter. Albert D Mason Inc.’s holdings in UnitedHealth Group were worth $281,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Chesapeake Wealth Management grew its holdings in shares of UnitedHealth Group by 7.0% in the fourth quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock valued at $2,647,000 after purchasing an additional 326 shares during the period. Two Sigma Investments LP acquired a new position in UnitedHealth Group in the fourth quarter valued at about $87,114,000. Beaumont Financial Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $2,299,000. Ruedi Wealth Management Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at about $64,000. Finally, Railway Pension Investments Ltd lifted its position in UnitedHealth Group by 1.4% in the fourth quarter. Railway Pension Investments Ltd now owns 426,020 shares of the healthcare conglomerate’s stock valued at $225,867,000 after buying an additional 5,800 shares during the last quarter. Hedge funds and other institutional investors own 92.61% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $479.19 on Friday. The firm’s fifty day moving average price is $485.88 and its 200 day moving average price is $493.04. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81. The firm has a market cap of $446.14 billion, a price-to-earnings ratio of 21.91, a price-to-earnings-growth ratio of 1.34 and a beta of 0.68.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The company had revenue of $91.93 billion during the quarter, compared to the consensus estimate of $89.77 billion. During the same quarter last year, the company earned $5.49 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.7% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 24.86 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 27th. Investors of record on Monday, June 19th will be paid a $1.88 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date is Thursday, June 15th. This represents a $7.52 annualized dividend and a dividend yield of 1.57%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.39%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on UNH. Piper Sandler began coverage on shares of UnitedHealth Group in a research report on Thursday, May 25th. They set an “overweight” rating and a $580.00 price target on the stock. Loop Capital increased their price target on shares of UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Monday, April 17th. Cantor Fitzgerald initiated coverage on shares of UnitedHealth Group in a research report on Thursday, April 20th. They set an “overweight” rating and a $591.00 price target on the stock. TD Cowen reduced their target price on shares of UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating on the stock in a report on Monday, April 17th. Finally, JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $595.00 to $562.00 in a report on Tuesday, May 30th. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $592.68.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of UnitedHealth Group stock in a transaction dated Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the completion of the transaction, the executive vice president now owns 10,359 shares in the company, valued at $5,019,764.22. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of UnitedHealth Group stock in a transaction dated Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the completion of the transaction, the executive vice president now owns 10,359 shares in the company, valued at $5,019,764.22. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. Insiders sold 8,852 shares of company stock worth $4,313,962 over the last 90 days. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.